ReShape Lifesciences Inc (NASDAQ:RSLS) traded at $0.36 at close of the session on Monday, March 31 and made a downward move of -6.82% on its previous day’s price.
Looking at the stock we see that its previous close was $0.39 and the beta (5Y monthly) reads 1.582 with the day’s price range being $0.3445 – $0.3976. In terms of its 52-week price range, RSLS has a high of $29.00 and a low of $0.39. The company’s stock has lost about -65.00% over that past 30 days.
ReShape Lifesciences Inc has a market cap of $1.19 million and is expected to release its quarterly earnings report on 2024-Nov-13.
On the other hand, looking at the outlook for the RSLS stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 100% Sell.
Based on estimates by 1 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the ReShape Lifesciences Inc (RSLS) stock as a Hold, while 1 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is -45.85% off its SMA20 and -81.28% from its 50-day simple moving average. The RSI (14) is pointing at 17.86 while the volatility over the past week is 17.35% and jumps to 14.31% over the past one month. The beta value is 1.60, while the average true range (ATR) is currently pointing at 0.14.
Coming back to ReShape Lifesciences Inc (NASDAQ:RSLS), we note that the average 3-month trading volume was 1.19 million, while that of the preceding 10-day period stands at 0.55 million. Current shares outstanding are 3.31 million.
The insiders hold 18.08% of the company’s shares while institutions hold 1.01%. The data shows that short shares as of 2025-03-14, stood at 0.37 million at a short ratio of 0.11. This represents a 1111.00 short interest in shares outstanding on 2025-03-14. Shares short rose in March from the previous month at 82814.0. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -91.92% down in year-to-date price movement.
